Hemosiderin Detection inside the Mammillary Bodies Using Quantitative Susceptibility Mapping on Patients with Wernicke-Korsakoff Syndrome

Nakamura, Y.; Fushimi, Yasutaka; Hinoda, Takuya; Nakajima, Satoshi; Sakata, Akihiko; Okuchi, Sachi; Otani, Sayo; Tagawa, Hiroshi; Wang, Yan; Ikeda, Satoshi; Kawashima, Hirotsugu; Uemura, Masanori; Nakamoto, Yuji

doi:10.2463/mrms.ici.2022-0109

Cited by 3 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Manganese accumulation and deposition in Alzheimer type II astrocytes in the globus pallidus are currently considered the main underlying cause of motor disorders associated with acquired hepatocerebral degeneration. 80 QSM showed 78 elevated susceptibility values in the globus pallidus, since manganese is a paramagnetic substance (Fig. 7).…”

Section: Hepatic Encephalopathymentioning

confidence: 93%

See 1 more Smart Citation

Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology

Fushimi,

Nakajima,

Sakata

et al. 2023

Magnetic Resonance Imaging

Self Cite

View full text Add to dashboard Cite

Quantitative susceptibility mapping (QSM) is a unique technique for providing quantitative information on tissue magnetic susceptibility using phase image data. QSM can provide valuable information regarding physiological and pathological processes such as iron deposition, hemorrhage, calcification, and myelin. QSM has been considered for use as an imaging biomarker to investigate physiological status and pathological changes. Although various studies have investigated the clinical applications of QSM, particularly regarding the use of QSM in clinical practice, have not been examined well. This review provides on an overview of the basics of QSM and its clinical applications in neuroradiology.Level of Evidence2Technical EfficacyStage 2

show abstract

Section: Hepatic Encephalopathymentioning

confidence: 93%

“…White arrows indicate mammillary bodies. This figure is reprinted with permission from Nakamura et al 78 …”

Section: Wernicke Encephalopathymentioning

confidence: 99%

Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology

Fushimi,

Nakajima,

Sakata

et al. 2023

Magnetic Resonance Imaging

Self Cite

View full text Add to dashboard Cite

show abstract

Wernicke Encephalopathy: Typical and Atypical Findings in Alcoholics and Non-Alcoholics and Correlation with Clinical Symptoms

Arendt,

Uckermark,

Kovacheva

et al. 2024

Clin Neuroradiol

View full text Add to dashboard Cite

Wernicke's Encephalopathy

Kulesh,

Demin,

Kaileva

2024

РНЖ

View full text Add to dashboard Cite

Wernicke encephalopathy is a thiamine deficiency condition that has a wide range of somatic causes in addition to alcohol abuse. Most patients do not have the classical clinical triad — oculomotor dysfunction, ataxia and cognitive impairment at the onset of the disease, which makes timely diagnosis difficult. The disease may manifest as dizziness, unsteadiness, double vision, or cognitive impairment. Key clinical manifestations include symmetrical gaze-evoked nystagmus, truncal ataxia, bilateral abducens paresis, internuclear ophthalmoplegia, bilateral vestibular-ocular reflex reduction, and anterograde amnesia. To make a diagnosis, the presence of a condition leading to thiamine deficiency is required. The diagnosis is confirmed by MRI, but even with clinical suspicion of Wernicke encephalopathy, it is necessary to initiate parenteral therapy with thiamine in an adequate dose. With timely treatment, the disease has a good prognosis.

show abstract

Hemosiderin Detection inside the Mammillary Bodies Using Quantitative Susceptibility Mapping on Patients with Wernicke-Korsakoff Syndrome

Cited by 3 publications

References 13 publications

Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology

Value of Quantitative Susceptibility Mapping in Clinical Neuroradiology

Wernicke Encephalopathy: Typical and Atypical Findings in Alcoholics and Non-Alcoholics and Correlation with Clinical Symptoms

Wernicke's Encephalopathy

Contact Info

Product

Resources

About